Silencing AHNAK promotes nasopharyngeal carcinoma progression by upregulating the ANXA2 protein

ConclusionHere, we report AHNAK as a tumor suppressor in NPC, which may act through annexin A2 oncogenic signaling in enlargeosome, with potential implications for novel approaches to NPC treatment.
Source: Cellular Oncology - Category: Cancer & Oncology Source Type: research